Merck pill acts against the Omicron variant
A total of six laboratory studies conducted internationally concluded that the merck’s pill remains “active” against Omicron variantreported this Friday the US drugmaker. The oral treatment, called molnupiravir, is taken within five days of symptom onset and, in a pre-Omicron trial of 1,400 participants, was shown to reduce COVID-19 hospitalizations and deaths by 30% among … Read more